A new market study on the 2022-2028 Western Blotting Market with 100+ market data Tables, Pie Chat, and Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry-validated market data. The report incorporates a broad evaluation of different methods like combinations and acquisitions, thing headways, and investigation and enhancements embraced by observable market pioneers to stay at the front line in the overall market.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2711
Global Western Blotting Market
A western blotting, immunoblotting, is a laboratory technique/method used to detect specific protein molecules from among a mixture of proteins. Various steps in western blotting include gel electrophoresis, transfer of proteins onto membrane, tissue preparation, blocking to prevent membrane, antibody interactions, incubation of membrane, and antibody-based detection of proteins. It works on the principle of molecular weight of the proteins and specificity.
High prevalence of HIV/AIDS around the world is expected to propel growth of the global western blotting market. For instance, as per the United Nations Program on HIV/AIDS, in 2018, more than 37.9 million people across the globe were living with HIV.
Moreover, increasing use of western blotting is expected to augment the growth of the global western blotting market. For instance, in January 2020, a British research council, the Natural Environment Research Council reported the use of western blotting in the assessment of EV profiles plasma and post-translationally deaminated proteins in seabird species from Antarctic.
Introduction of novel software for managing western blotting results is expected to provide significant growth opportunities for players operating in the market. Western blotting generates a large amount of data, and thus, it needs to be interpreted, organized, and stored.
Moreover, market players are focusing on developing novel products to strengthen their market presence. Players in the market are focusing in launching digital western blotting methods to improve end-results.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/2711
- Scientific Research
- Medical Diagnostics
- Agricultural Application
- Food & Beverages
- Other Applications
By End User:
- Diagnostic Laboratories
- Research Institutions
- Pharmaceutical & Biotechnology Companies
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
High preference for alternative technologies, such as AlphaScreen technology, is expected to hinder growth of the global western blotting market.
Moreover, western blotting is a semi-quantitative procedure and can only give an approximate measurement. This in turn is also expected to hamper growth of the market.
Market Trends/Key Takeaways:
Increasing use of western blotting in cancer research is expected to aid in the growth of the global western blotting market. For instance, in January 2020, a team of researchers from the First Affiliated Hospital of Soochow University, China used western blot to investigate the role of miR-708 (microRNA-708) in cervical cancer.
Moreover, increasing applications of fluorescent blotting in protein detection is expected to fuel growth of the global western blotting market.
Key players active in the global western blotting market are Advansta, Inc., PerkinElmer Inc., Bio-Rad Laboratories, Inc., LI-COR, Inc., EMD Millipore Corporation, Hoffmann-La Roche Ltd., GE Healthcare, Thermo Fisher Scientific, Inc., Lumigen, Inc. (Danaher Corporation), and Bio-Techne Corporation (ProteinSimple Inc.), among others.
Market players adopting various strategies, such as mergers and acquisitions, to enhance their market share. For instance, in June 2019, Bio-Techne Corp. announced that it has acquired all of the stock of B-MoGen Biotechnologies Inc.
Moreover, market players focusing on launching novel products to meet growing demand. For instance, in November 2019, Bio-Rad announced the launch of EveryBlot Blocking Buffer, a western blot that offers five-minute blocking time and produces lower background levels and higher signal resulting in greater sensitivity compared to other available blocking buffers.
Buy This Report And Get Quick Access – https://www.coherentmarketinsights.com/insight/buy-now/2711
Table Of Content
Chapter No. 1 Introduction
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. USP & Key Offerings
1.2. Key Benefits for Stakehulders
1.3. Target Audience
1.4. Report Scope
Chapter No. 2 Executive Summary
2.1. Key Findings
2.1.1. Top Investment Pockets
18.104.22.168. Market Attractiveness Analysis, By Type
22.214.171.124. Market Attractiveness Analysis, By End Use
126.96.36.199. Market Attractiveness Analysis, By Region
2.2. Market Snapshot
2.3. Global Western Blotting Market, 2017 – 2022 (USD Million)
2.4. Insights from Primary Respondents
Chapter No. 3 COVID 19 Impact Analysis
3.1. Impact Assessment of COVID-19 Pandemic, By Region
3.1.1. North America
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. The Middle-East and Africa
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027